Research Article

Spectrophotometric determination of Meloxicam in Pure Form and its Pharmaceutical Formulation following azo dye formation with 4-nitroaniline

Volume: 11 Number: 4 December 3, 2024
EN

Spectrophotometric determination of Meloxicam in Pure Form and its Pharmaceutical Formulation following azo dye formation with 4-nitroaniline

Abstract

A fast, cheap, and straightforward spectrophotometric method has been proposed to determine meloxicam (MEL) in its pure form and pharmaceutical formulation. The technique involves diazotizing the (NH2) group in 4-nitroaniline with NaNO2 followed by a reaction with meloxicam to produce a stable and colored complex in a basic medium. This complex demonstrates maximum absorbance at 514 nm. The developed method's linearity ranges from 2.0 - 25 μg mL-1, and the molar absorptivity is 1.5989×104 L mol-1 cm-1. The RSD% is lower than 1.55%. Additionally, the limit of detection (LOD) is 0.2019 μg mL-1. The method successfully determines the pharmaceutical preparation containing meloxicam (Loxim tablets) with a recovery rate of no less than 97.9%.

Keywords

Supporting Institution

No funding was received for conducting this study

Ethical Statement

The authors declare that their study does not need ethical approval from an ethics committee.

References

  1. 1. Chaudhary M, Bhardwaj K, Verma G, Kumar P. Validated analytical method development for the determination of Meloxicam by UV spectroscopy in API and pharmaceutical dosage form. Asian J Pharm Educ Res [Internet]. 7(2):60–9. Available from: .
  2. 2. Hasan SH, Othman NS, Surchi KM. Spectrophotometric method for determination of meloxicam in pharmaceutical formulations using N-bromosuccinimide as an oxidant. Int J Pharma Sci Res [Internet]. 2014;5(12):963–9. Available from: .
  3. 3. Ganna Olegivna S, Tetyana Stanislavivna T, Olga Leonidivna L, Olena Valeryivna S. Biochemical confirmation of anti-inflammatory activity of oxicam-based pharmaceutical compositions. J Turkish Chem Soc Sect A Chem [Internet]. 2018 Sep 1;5(3):1407–12. Available from: .
  4. 4. Donchenko A, Vasyuk S, Nahorna N. Extraction-free spectrophotometric determination of meloxicam using bromothymol blue. Ankara Univ Eczac Fak Derg [Internet]. 2023 Jul 17;47(3):752–60. Available from: .
  5. 5. Abbas RF, Mahdi NI, Waheb AA, Aliwi AG, Falih MS. Fourth derivative and compensated area under the curve spectrophotometric methods used for analysis meloxicam in the local market tablet. Al-Mustansiriyah J Sci [Internet]. 2018;29(3):70–6. Available from: .
  6. 6. Gurupadayya BM, Trinath MN, Shilpa & K. Spectrophotometric determination of meloxicam by sodium nitroprusside and 1,10-phenanthroline reagents in bulk and its pharmaceutical formulation. Indian J Chem Technol [Internet]. 2013;20:111–5. Available from: .
  7. 7. Mahood AM, Najm NH. Spectrophotometric estamation of meloxicam using charge transfer complex. IOP Conf Ser Mater Sci Eng [Internet]. 2019 Jul 1;571(1):012081. Available from: .
  8. 8. Chaplenko AA, Monogarova O V., Oskolok K V. Spectroscopic and colorimetric determination of meloxicam, lornoxicam, tenoxicam in drugs. Int J Pharm Biol Arch [Internet]. 2018 Apr 26;9(1):31–5. Available from: .

Details

Primary Language

English

Subjects

Analytical Spectrometry

Journal Section

Research Article

Publication Date

December 3, 2024

Submission Date

March 12, 2024

Acceptance Date

August 22, 2024

Published in Issue

Year 2024 Volume: 11 Number: 4

APA
Atiyah, A., Hussein, K., & Ahmed, A. M. (2024). Spectrophotometric determination of Meloxicam in Pure Form and its Pharmaceutical Formulation following azo dye formation with 4-nitroaniline. Journal of the Turkish Chemical Society Section A: Chemistry, 11(4), 1461-1472. https://doi.org/10.18596/jotcsa.1451322
AMA
1.Atiyah A, Hussein K, Ahmed AM. Spectrophotometric determination of Meloxicam in Pure Form and its Pharmaceutical Formulation following azo dye formation with 4-nitroaniline. JOTCSA. 2024;11(4):1461-1472. doi:10.18596/jotcsa.1451322
Chicago
Atiyah, Ali, Kameran Hussein, and Abdul Majeed Ahmed. 2024. “Spectrophotometric Determination of Meloxicam in Pure Form and Its Pharmaceutical Formulation Following Azo Dye Formation With 4-Nitroaniline”. Journal of the Turkish Chemical Society Section A: Chemistry 11 (4): 1461-72. https://doi.org/10.18596/jotcsa.1451322.
EndNote
Atiyah A, Hussein K, Ahmed AM (December 1, 2024) Spectrophotometric determination of Meloxicam in Pure Form and its Pharmaceutical Formulation following azo dye formation with 4-nitroaniline. Journal of the Turkish Chemical Society Section A: Chemistry 11 4 1461–1472.
IEEE
[1]A. Atiyah, K. Hussein, and A. M. Ahmed, “Spectrophotometric determination of Meloxicam in Pure Form and its Pharmaceutical Formulation following azo dye formation with 4-nitroaniline”, JOTCSA, vol. 11, no. 4, pp. 1461–1472, Dec. 2024, doi: 10.18596/jotcsa.1451322.
ISNAD
Atiyah, Ali - Hussein, Kameran - Ahmed, Abdul Majeed. “Spectrophotometric Determination of Meloxicam in Pure Form and Its Pharmaceutical Formulation Following Azo Dye Formation With 4-Nitroaniline”. Journal of the Turkish Chemical Society Section A: Chemistry 11/4 (December 1, 2024): 1461-1472. https://doi.org/10.18596/jotcsa.1451322.
JAMA
1.Atiyah A, Hussein K, Ahmed AM. Spectrophotometric determination of Meloxicam in Pure Form and its Pharmaceutical Formulation following azo dye formation with 4-nitroaniline. JOTCSA. 2024;11:1461–1472.
MLA
Atiyah, Ali, et al. “Spectrophotometric Determination of Meloxicam in Pure Form and Its Pharmaceutical Formulation Following Azo Dye Formation With 4-Nitroaniline”. Journal of the Turkish Chemical Society Section A: Chemistry, vol. 11, no. 4, Dec. 2024, pp. 1461-72, doi:10.18596/jotcsa.1451322.
Vancouver
1.Ali Atiyah, Kameran Hussein, Abdul Majeed Ahmed. Spectrophotometric determination of Meloxicam in Pure Form and its Pharmaceutical Formulation following azo dye formation with 4-nitroaniline. JOTCSA. 2024 Dec. 1;11(4):1461-72. doi:10.18596/jotcsa.1451322

Cited By